CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 102 enrolled
Drug / intervention
AURYON Atherectomy Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04229563
NCT04229563N/ACompleted
CompareCT.gov

PATHFINDER Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease (EX-PAD-05)

Angiodynamics, Inc.·observational·Posted Jan 18, 2020·Updated May 18, 2026

In Brief

An observational study evaluating AURYON Atherectomy System for Infrainguinal Peripheral Artery Disease and 2 related conditions. Completed, enrolled 102 participants across 10 sites.

Detailed Summary

The PATHFINDER Registry is a prospective, non-randomized, single arm, multicenter observational study. This pilot registry is aimed to evaluate the performance (peri-procedural) and clinical outcomes (intermediate and long-term) of the AURYON Atherectomy System, within the initial launch phase of the product in the market.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInfrainguinal Peripheral Artery Disease, Peripheral Arterial Disease, PAD
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 18, 2020
Enrollment StartAug 4, 2020
Primary CompletionMar 17, 2021
Study CompletionApr 17, 2023
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 6.5 years ago

Interventions

AURYON Atherectomy Systemdevice

The AURYON Atherectomy System consists of two sub-units: 1) a single use catheter ("AURYON™ catheter"); and 2) a laser system.